Genome-wide interaction study of smoking and bladder cancer risk
- PMID: 24662972
- PMCID: PMC4123644
- DOI: 10.1093/carcin/bgu064
Genome-wide interaction study of smoking and bladder cancer risk
Abstract
Bladder cancer is a complex disease with known environmental and genetic risk factors. We performed a genome-wide interaction study (GWAS) of smoking and bladder cancer risk based on primary scan data from 3002 cases and 4411 controls from the National Cancer Institute Bladder Cancer GWAS. Alternative methods were used to evaluate both additive and multiplicative interactions between individual single nucleotide polymorphisms (SNPs) and smoking exposure. SNPs with interaction P values < 5 × 10(-) (5) were evaluated further in an independent dataset of 2422 bladder cancer cases and 5751 controls. We identified 10 SNPs that showed association in a consistent manner with the initial dataset and in the combined dataset, providing evidence of interaction with tobacco use. Further, two of these novel SNPs showed strong evidence of association with bladder cancer in tobacco use subgroups that approached genome-wide significance. Specifically, rs1711973 (FOXF2) on 6p25.3 was a susceptibility SNP for never smokers [combined odds ratio (OR) = 1.34, 95% confidence interval (CI) = 1.20-1.50, P value = 5.18 × 10(-) (7)]; and rs12216499 (RSPH3-TAGAP-EZR) on 6q25.3 was a susceptibility SNP for ever smokers (combined OR = 0.75, 95% CI = 0.67-0.84, P value = 6.35 × 10(-) (7)). In our analysis of smoking and bladder cancer, the tests for multiplicative interaction seemed to more commonly identify susceptibility loci with associations in never smokers, whereas the additive interaction analysis identified more loci with associations among smokers-including the known smoking and NAT2 acetylation interaction. Our findings provide additional evidence of gene-environment interactions for tobacco and bladder cancer.
Published by Oxford University Press 2014.
Figures


Similar articles
-
Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.PLoS One. 2012;7(12):e51880. doi: 10.1371/journal.pone.0051880. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284801 Free PMC article.
-
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Eur Urol. 2023 Jul;84(1):127-137. doi: 10.1016/j.eururo.2023.04.020. Epub 2023 May 19. Eur Urol. 2023. PMID: 37210288 Free PMC article.
-
Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.PLoS One. 2013 Dec 31;8(12):e83745. doi: 10.1371/journal.pone.0083745. eCollection 2013. PLoS One. 2013. PMID: 24391818 Free PMC article.
-
N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.Br J Cancer. 2000 Aug;83(3):412-7. doi: 10.1054/bjoc.2000.1265. Br J Cancer. 2000. PMID: 10917561 Free PMC article. Review.
-
Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.Clin Genitourin Cancer. 2016 Apr;14(2):122-9. doi: 10.1016/j.clgc.2015.10.007. Epub 2015 Oct 26. Clin Genitourin Cancer. 2016. PMID: 26585839 Review.
Cited by
-
Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size.Transl Androl Urol. 2020 Jun;9(3):1329-1337. doi: 10.21037/tau-19-523. Transl Androl Urol. 2020. PMID: 32676417 Free PMC article.
-
Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.Biomed Res Int. 2015;2015:623121. doi: 10.1155/2015/623121. Epub 2015 Nov 3. Biomed Res Int. 2015. PMID: 26613085 Free PMC article.
-
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.Aging (Albany NY). 2023 Nov 13;15(21):12674-12697. doi: 10.18632/aging.205205. Epub 2023 Nov 13. Aging (Albany NY). 2023. PMID: 37963845 Free PMC article.
-
A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regression.Pac Symp Biocomput. 2015:183-94. Pac Symp Biocomput. 2015. PMID: 25592580 Free PMC article.
-
RIFS: a randomly restarted incremental feature selection algorithm.Sci Rep. 2017 Oct 12;7(1):13013. doi: 10.1038/s41598-017-13259-6. Sci Rep. 2017. PMID: 29026108 Free PMC article.
References
-
- Silverman D.T., et al. (2006). Bladder cancer. In Fraumeni J.F., Jr, Schottenfeld D. (eds) Cancer Epidemiology and Prevention Third Edition. Oxford University Press, New York, NY, pp. 1101–1127
Publication types
MeSH terms
Substances
Grants and funding
- U01HG004446/HG/NHGRI NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- CA34627/CA/NCI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- NCI N02-CP-01037/CP/NCI NIH HHS/United States
- R01CA65726/CA/NCI NIH HHS/United States
- R01CA114665/CA/NCI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- R01 CA057494/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- 16491/CRUK_/Cancer Research UK/United Kingdom
- U01HG004438/HG/NHGRI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 HG004446/HG/NHGRI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA67262/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- BHF_/British Heart Foundation/United Kingdom
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- R01 CA065726/CA/NCI NIH HHS/United States
- N02 CP001037/CP/NCI NIH HHS/United States
- N02 CP011015/CP/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01-CA089715/CA/NCI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- R01 CA089715/CA/NCI NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- R01 CA114665/CA/NCI NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- 1P01CA86871/CA/NCI NIH HHS/United States
- MRC_/Medical Research Council/United Kingdom
- HHSN271201100004C/AG/NIA NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- NCI N02-CP-11015/CP/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01HL091172-01/HL/NHLBI NIH HHS/United States
- P01 CA086871/CA/NCI NIH HHS/United States
- R01 CA034627/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- CA055075/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- HHSN268201100001C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous